Cite
HARVARD Citation
Schadendorf, D. et al. (2020). Quality‐of‐life analysis with intermittent vismodegib regimens in patients with multiple basal cell carcinomas: patient‐reported outcomes from the MIKIE study. Journal of the European Academy of Dermatology and Venereology. pp. e526-e529. [Online].